Insulin Costs Remain High for Many Americans Despite Progress
Event summary
- 72% of insulin users pay more than $35/month, with nearly 40% paying over $150/month.
- Middle-class Americans (earning $50k–$99k) are disproportionately affected, with 44–55% paying over $150/month.
- 76% of survey respondents support a $35 monthly cap on insulin cost-sharing.
- Bipartisan INSULIN Act of 2026 aims to limit out-of-pocket costs for private/employer-sponsored plans to $35/month.
The big picture
Despite progress in reducing insulin costs for Medicare and some state programs, private and employer-sponsored plans still leave many Americans vulnerable to high out-of-pocket expenses. The ADA's survey highlights the financial strain on middle-class households, reinforcing the need for federal intervention. With bipartisan legislation introduced, the debate over healthcare affordability is likely to intensify.
What we're watching
- Legislative Momentum
- Whether the INSULIN Act gains traction in Congress amid bipartisan support.
- Market Response
- How pharmaceutical companies and insurers react to potential cost-sharing caps.
- Consumer Behavior
- The impact of high insulin costs on rationing and healthcare utilization trends.
Related topics